Octreotide

Ref. 3D-PP49921

Informations sur le produit

• Nom: Octreotide

Description

Peptide Octreotide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Octreotide include the following: Synthesis and in vitro study of the anticancer activity of new analogs of octreotide S Staykova, E Naydenova - Protein and Peptide , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ppl/2012/00000019/00000012/art00004 Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release RD Vaishya, A Mandal , S Patel , AK Mitra - International journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517315303525 Long-term follow-up of renal function after peptide receptor radiation therapy with 90Y-DOTA0, Tyr3-octreotide and 177Lu-DOTA0, Tyr3-octreotate R Valkema, SA Pauwels, LK Kvols - Journal of nuclear , 2005 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/46/1_suppl/83S.short Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0, Tyr3] octreotide in patients with advanced gastroenteropancreatic R Valkema, S Pauwels, LK Kvols, R Barone - Seminars in nuclear , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000129980600002X Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0] octreotide: the Rotterdam experience R Valkema, M De Jong, WH Bakker - Seminars in nuclear , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0001299802800290 Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland R Deghenghi, M Papotti, E Ghigo, G Muccioli - Endocrine, 2001 - Springerhttps://link.springer.com/article/10.1385/ENDO:14:1:029 Gold nanoparticles conjugated to [Tyr3] octreotide peptide PP Surujpaul , C Gutierrez-Wing, B Ocampo-Garcaca­a - Biophysical , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301462208001737 Octreotide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion PE Battershill, SP Clissold - Drugs, 1989 - Springerhttps://link.springer.com/article/10.2165/00003495-198938050-00002 Analytical quality-by-design optimization of UHPLC method for the analysis of octreotide release from a peptide-based hydrogel in-vitro PD Tzanavaras , AT Chatzitaki , C Karavasili - of Pharmaceutical and , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708522001200 A novel facile method of labeling octreotide with 18F-fluorine P Laverman, WJ McBride, RM Sharkey - Journal of nuclear , 2010 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/51/3/454.short Effect of conformation on the photodegradation of Trp-and cystine-containing cyclic peptides: octreotide and somatostatin O Mozziconacci, C Schöneich - Molecular pharmaceutics, 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/mp5003174 Octreotide-mediated tumor-targeted drug delivery via a cleavable doxorubicin-peptide conjugate M Lelle, S Kaloyanova, C Freidel - Molecular , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.5b00487 Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy M De Jong, WH Bakker, WAP Breeman - journal of cancer, 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19980130)75:3%3C406::AID-IJC14%3E3.0.CO;2-6 Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount M de Jong, WAP Breeman, BF Bernard - European journal of , 1999 - Springerhttps://link.springer.com/article/10.1007/s002590050439 213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model JP Norenberg , BJ Krenning, IRHM Konings - Clinical Cancer , 2006 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/12/3/897/194211 Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT? JP Esser, EP Krenning, JJM Teunissen - European journal of , 2006 - Springerhttps://link.springer.com/article/10.1007/s00259-006-0172-9 Gastrointestinal peptide hormones during postoperative ileus: Effect of octreotide JJ Cullen, JC Eagon, KA Kelly - Digestive diseases and sciences, 1994 - Springerhttps://link.springer.com/article/10.1007/BF02093781 Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly (lactide-co-glycolide) delivery systems JH Ahn, EJ Park, HS Lee, KC Lee, DH Na - Aaps Pharmscitech, 2011 - Springerhttps://link.springer.com/article/10.1208/s12249-011-9694-y Octreotide G Stajich , L Ashworth - Neonatal Network, 2006 - connect.springerpub.comhttps://connect.springerpub.com/content/sgrnn/25/5/365.abstract Production of peptides as generic drugs: a patent landscape of octreotide G Sabatino , I Guryanov, A Rombecchi - Expert Opinion on , 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/13543776.2016.1158810 Enteral absorption of octreotide G Flicker, J Drewe , J Vonderscher - British journal of , 1992 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.1992.tb09057.x Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin FA Dorkoosh , JC Verhoef, MHC Ambagts - European journal of , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0928098702000283 Structure of octreotide, a somatostatin analogue E Pohl, A Heine, GM Sheldrick , Z Dauter - Section D: Biological , 1995 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?gr0269 Evaluation of [99mTc/EDDA/HYNIC0] octreotide derivatives compared with [111In-DOTA0, Tyr3, Thr8] octreotide and [111In-DTPA0] octreotide: does tumor or D Storch, M Behe , MA Walter , J Chen - Journal of nuclear , 2005 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/46/9/1561.short Versatile conjugation of octreotide to dendrimers by cycloaddition ("œclick") chemistry to yield high-affinity multivalent cyclic peptide dendrimers CB Yim, OC Boerman, M de Visser - Bioconjugate , 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc900052n A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a C Parkinson, WM Drake, ME Roberts - The Journal of , 2002 - academic.oup.comhttps://academic.oup.com/jcem/article-abstract/87/4/1797/2374984 From bulk to plasmonic nanoparticle surfaces: the behavior of two potent therapeutic peptides, octreotide and pasireotide B Hernandez , E Lopez-Tobar - Physical Chemistry , 2016 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2016/cp/c6cp04421b Controlled release of octreotide and assessment of peptide acylation from poly (D, L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres AH Ghassemi, MJ van Steenbergen - Pharmaceutical , 2012 - Springerhttps://link.springer.com/article/10.1007/s11095-011-0517-3 Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced osteomalacia A Nair , S Chakraborty, P Dharmshaktu - Journal of the , 2017 - academic.oup.comhttps://academic.oup.com/jes/article-abstract/1/6/726/3788875 Locoregional Regulatory Peptide Receptor Targeting with the Diffusible Somatostatin Analogue 90Y-Labeled DOTA0-d-Phe1-Tyr3-octreotide (DOTATOC): A Pilot A Merlo, O Hausmann, M Wasner, P Steiner, A Otte - Clinical cancer , 1999 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/5/5/1025/287501 Peptide receptor radionuclide therapy in vitro using [111In-DTPA0] octreotide A Capello, EP Krenning, WAP Breeman - Journal of Nuclear , 2003 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/44/1/98.short Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications A Accardo , A Morisco, E Gianolio - Journal of peptide , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.1308

• Marque: Biosynth